ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Patient Medical history System Proposed

July 13, 1979

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986

NCI Says Breast Cancer Rate In Marin Matches Other West Coast Counties

April 18, 2003